Identifying risk factors for Refeeding Syndrome in ICU patients
Risk Factors for Refeeding Syndrome in the Surgical Intensive Care Unit
This study looks at what factors might put undernourished ICU patients at risk for Refeeding Syndrome when they start receiving nutrition again.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Samsun University Academic / other |
| Locations | 1 site (Samsun) |
| Trial ID | NCT06054139 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify the risk factors associated with Refeeding Syndrome in patients admitted to the Surgical Intensive Care Unit (ICU). It focuses on patients who are undernourished and may experience serious electrolyte disturbances when re-fed. The study will monitor patients receiving nutritional support according to established guidelines while investigating the development of Refeeding Syndrome and its contributing factors. By understanding these risk factors, the study seeks to improve nutritional protocols and patient outcomes in the ICU setting.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients over 18 years old who are admitted to the ICU and require nutritional support.
Not a fit: Patients with conditions such as diabetic ketoacidosis, terminal stage cancer, or severe neurological impairment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better prevention strategies for Refeeding Syndrome, ultimately improving patient safety and outcomes in the ICU.
How similar studies have performed: While there have been studies on Refeeding Syndrome, this specific observational approach to identify risk factors in ICU patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients are intensive care patients 2. Patients' age \> 18 - Exclusion Criteria: 1. Diabetic ketoacidosis 2. Other risk factors for hypophosphatemia (patients on continuous hemodialysis, hyperphosphatemia treatment, parathyroidectomy) 3. Patients with pre-study hypophosphatemia (\< 0.65 mmol/L) 4. Patients with hyperparathyroidism 5. Terminal stage cancer patients 6. Patients with Glasgow Coma Scale ≤5 7. Patients with respiratory and metabolic alkalosis -
Where this trial is running
Samsun
- Şerife Seçgin — Samsun, Turkey (Recruiting)
Study contacts
- Study coordinator: Şeri̇fe Seçgi̇n
- Email: kuvez@hotmail.com
- Phone: +905556166112
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.